VPEUR Performance — ProFund VP Europe 30
Data updated: 2026-08-28
VPEUR returned +20.47% year to date and +36.05% over one year to Jun 2026. Annualised returns are +21.01% over 3 years and +12.87% over 5 years. The fund beat its Europe Equity category average: $100 invested three years ago grew to $177, against $151 for the category, and to $136 over one year, against $114. Volatility over the past three years was 11.23% a year. In the 12 months to Jun 2026 the fund lost a net $5.6M, and assets reached $16.81M.
VPEUR Growth of $100
What $100 invested in ProFund VP Europe 30 grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Europe Equity category average over the same months.
| Period | VPEUR | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $136 | $114 |
| 3 years (Jul 2023 – Jun 2026) | $177 | $151 |
| 5 years (Jul 2021 – Jun 2026) | $183 | $141 |
| Since data start (Jul 2019 – Jun 2026) | $206 | $183 |
VPEUR Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +20.47% |
| 1 year | +36.05% |
| 3 years (annualised) | +21.01% |
| 5 years (annualised) | +12.87% |
VPEUR Annual Returns
Calendar-year total returns of ProFund VP Europe 30, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +20.47% |
| 2025 | +29.59% |
| 2024 | +4.36% |
| 2023 | +17.44% |
| 2022 | −7.75% |
| 2021 | +24.51% |
| 2020 | −9.24% |
| 2019 (Jul–Dec) | +3.39% |
VPEUR Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +7.1% | +4.2% | −3.2% | +7.4% | +5.6% | −1.6% | — | — | — | — | — | — |
| 2025 | +5.8% | +1.7% | −0.9% | +0.5% | +4.3% | +2.6% | −2.7% | +5.7% | +2.5% | +4.0% | +1.8% | +1.1% |
| 2024 | −1.0% | +1.6% | +4.0% | −1.6% | +4.3% | −2.0% | +2.3% | +3.1% | +0.5% | −4.7% | −0.5% | −1.6% |
| 2023 | +6.1% | −1.5% | +1.6% | +1.6% | −5.0% | +5.4% | +2.1% | −0.6% | −1.8% | −2.3% | +7.5% | +4.0% |
| 2022 | +0.9% | −2.9% | +2.1% | −6.8% | +5.5% | −8.5% | +1.5% | −3.7% | −10.6% | +8.1% | +10.7% | −2.0% |
| 2021 | +1.9% | +4.5% | +3.1% | +5.4% | +4.8% | −1.1% | +1.1% | +2.1% | −2.9% | +5.2% | −5.6% | +4.3% |
| 2020 | −4.4% | −9.3% | −15.6% | +5.5% | +4.1% | +2.0% | +2.0% | +0.3% | −5.1% | −6.8% | +18.9% | +2.8% |
| 2019 | — | — | — | — | — | — | −2.1% | −3.9% | +2.4% | +1.7% | +1.8% | +3.6% |
VPEUR Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 11.23%
- 3-year Sharpe ratio: 1.47 (vs 4.5% risk-free rate)
- Best month: +7.51% (Nov 2023)
- Worst month: −4.66% (Oct 2024)
VPEUR Fund Flows
Monthly money in and out of ProFund VP Europe 30, from SEC Form N-PORT.
- 12-month net flow: −$5.6M
- 12-month gross sales (incl. reinvestments): $33.1M
- Sales ÷ redemptions: 0.85×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $3.3M | $2.3M | $1.1M |
| May 2026 | $2.2M | $2.9M | −$687K |
| Apr 2026 | $2.2M | $1.9M | $271K |
| Mar 2026 | $1.8M | $3.7M | −$1.9M |
| Feb 2026 | $1.4M | $1.4M | $5K |
| Jan 2026 | $1.2M | $2.0M | −$727K |
| Dec 2025 | $1.7M | $835K | $836K |
| Nov 2025 | $4.9M | $5.4M | −$513K |
| Oct 2025 | $6.9M | $7.1M | −$185K |
| Sep 2025 | $3.1M | $4.6M | −$1.5M |
| Aug 2025 | $1.4M | $637K | $715K |
| Jul 2025 | $3.0M | $6.1M | −$3.0M |
VPEUR Assets Under Management
Net assets of ProFund VP Europe 30 by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $16.81M |
| 2026-03-31 | $15.86M |
| 2025-12-31 | $17.17M |
| 2025-09-30 | $15.83M |
| 2025-06-30 | $19.62M |
| 2025-03-31 | $19.81M |
| 2024-12-31 | $11.04M |
| 2024-09-30 | $13.42M |
| 2024-06-30 | $14.86M |
| 2024-03-31 | $14.98M |
| 2023-12-31 | $15.53M |
| 2023-09-30 | $13.50M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.